Durvalumab Long-Term Safety and Efficacy Study
Clinical trial NCT04078152 · COMPLETED
Trial details
- NCT number
- NCT04078152
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-05
- Primary completion
- 2022-10-31
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.